Mark Alan Goldberg - 29 Sep 2023 Form 4 Insider Report for ImmunoGen, Inc.

Role
Director
Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Sep 2023
Net transactions value
+$16,870
Form type
4
Filing time
02 Oct 2023, 17:05:25 UTC
Previous filing
05 Jul 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $16,870 +1,063 +1.8% $15.87 60,151 29 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock issued pursuant to the Compensation Policy for Non-Employee Directors as amended June 14, 2023 in lieu of cash compensation for services performed for the quarter ended September 30, 2023.